News tagged with biological treatment
Cancer biorepository speeds clinical trials, drug development, analysis shows
Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial ...
Cancer
May 08, 2013 |
not rated yet |
0
Deficiency in p53 anti-tumor protein delays DNA repair after radiation
Researchers at Moffitt Cancer Center have found that a deficiency in an important anti-tumor protein, p53, can slow or delay DNA repair after radiation treatment. They suggest that this is because p53 regulates the expression ...
Cancer
Apr 23, 2013 |
4 / 5 (1) |
0
|
Chemical shift MRI helps differentiate renal cell tumors more likely to metastasize
Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment ...
Cancer
Apr 19, 2013 |
not rated yet |
0
BRAF mutation less common among patients with melanoma in Ireland
The BRAF mutation believed to drive disease in about half of patients with melanoma was found to occur at a significantly lower frequency in patients with melanoma in Ireland, according to data presented at the AACR Annual ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Common gene variants explain 42% of antidepressant response
Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment. The National Institute of Mental Health's STAR*D study, the largest and longest ...
Psychology & Psychiatry
Mar 28, 2013 |
4 / 5 (1) |
0
New research looks at novel ways to combat drug resistance
University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.
Medical research
Mar 27, 2013 |
5 / 5 (1) |
0
Ganetespib shows potency against ALK-positive lung cancer and overcomes crizotinib resistance
A drug that indirectly impairs the function of several cancer-driving proteins, including anaplastic lymphoma kinase (ALK), may be an effective new treatment for patients with ALK—positive non-small cell lung cancer.
Cancer
Mar 26, 2013 |
not rated yet |
0
New study identifies unique mechanisms of antibiotic resistance
As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms ...
Diseases, Conditions, Syndromes
Mar 26, 2013 |
5 / 5 (2) |
0
|
A step forward in the treatment of chronic urticaria
An international study involving dermatologists from the Hospital del Mar and Spanish subjects has concluded that a drug normally used to treat severe bronchial asthma caused by allergies (Omalizumab) rapidly eliminates the ...
Diseases, Conditions, Syndromes
Mar 20, 2013 |
5 / 5 (1) |
0
Promising new drug treats and protects against radiotherapy-associated oral mucositis
Mouse model studies show that administered genetically or topically, protein Smad7 protects against or heals mouth sores commonly associated with cancer treatment.
Cancer
Mar 12, 2013 |
not rated yet |
0
|
New effort to identify Parkinson's biomarkers
Last month, the National Institutes of Health announced a new collaborative initiative that aims to accelerate the search for biomarkers—changes in the body that can be used to predict, diagnose or monitor a disease—in ...
Parkinson's & Movement disorders
Mar 05, 2013 |
5 / 5 (1) |
0
Study identifies growth factor essential to the most common malignant pediatric brain tumor
A multi-institutional team led by Massachusetts General Hospital (MGH) researchers has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common ...
Cancer
Feb 28, 2013 |
not rated yet |
0
|
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study ...
Cancer
Feb 07, 2013 |
not rated yet |
0
Discovering the secrets of tumor growth
Scientists at the University of Copenhagen's Center for Healthy Ageing have identified a compound that blocks the expression of a protein without which certain tumours cannot grow. This compound has the potential as an anticancer ...
Cancer
Jan 24, 2013 |
not rated yet |
0
Helping healthy cells could be key to fighting leukemia, research suggests
Researchers at Imperial College London have shown that keeping healthy blood cells alive could be a more important tool in the fight against leukaemia than keeping cancerous cells at bay.
Cancer
Jan 22, 2013 |
5 / 5 (1) |
0
